LegisTrack
Back to all bills
S 63119th CongressIn Committee

CBW Fentanyl Act

Introduced: Jan 9, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs

The CBW Fentanyl Act, officially titled the Countering Beijing's Weaponization of Fentanyl Act, would amend the Chemical and Biological Weapons Control and Warfare Elimination Act of 1991 to create a new framework for sanctioning foreign countries in response to acts related to chemical or biological programs that injure other countries. The bill sets up a process for the President to determine whether a foreign official committed a “covered act” tied to a chemical or biological program, and it would trigger escalating sanctions on the foreign country most closely associated with that entity. It also expands the definition of what counts as a chemical/biological program to include fentanyl-related precursors and certain fentanyl-related chemicals. The act outlines specific initial, intermediate, and final sanctions, reporting requirements to Congress, a possible waiver, and a sunset provision after five years. In short, it creates a new, time-bound sanctions pathway tied to acts involving chemical/biological programs—explicitly including fentanyl precursors—that could affect bilateral relationships with targeted countries. Key elements include: a new section 310 establishing sanctions on countries in response to covered acts; expanded presidential reporting obligations about chemical/biological weapon acts or program acts; new definitions that include fentanyl precursors (benzylfentanyl, 4-anilinopiperidine, norfentanyl precursors); and a staged sanctions regime with potential termination or waivers, subject to Congress and national-security considerations.

Key Points

  • 1New title and purpose: Opens the CBW Act to create sanctions specifically in response to acts concerning chemical or biological programs that injure other countries, with a focus on fentanyl-related precursors and chemicals (the “CBW Fentanyl Act”).
  • 2Expanded definitions: Defines “chemical or biological program” to include benzylfentanyl, 4-anilinopiperidine, and norfentanyl precursors, broadening what is sanctionable beyond traditional chemical/biological weapons programs.
  • 3Determination process: Requires the President to make a determination within 60 days after credible information indicates a foreign official has committed a “covered act” concerning a chemical/biological program, and to apply sanctions if a covered act is found.
  • 4Sanctions framework (Section 310):
  • 5- Initial sanctions within 30 days of a positive determination: suspend all scientific cooperative programs with the country, prohibit certain exports (Category 1 or 2 items under the Commerce Control List), and prohibit procurement from chemical/biological sectors of the country.
  • 6- Intermediate sanctions (within 120 days): Congress gets a report on whether the country has addressed the act and complied with treaties; if not, at least two additional sanctions may be imposed (e.g., cutting foreign aid, restricting exports under EAR, or blocking certain licenses for Munitions List items).
  • 7- Final sanctions (within 210 days): a comprehensive report; if not addressed, the President must prohibit any foreign transactions involving U.S. financial interests with the country; potential continuation or adjustment of sanctions based on subsequent findings.
  • 8- Termination and restitution: sanctions can be terminated after one year if the country adequately addresses the act, restitution is provided, information is disclosed, and treaty obligations are met.
  • 9- Waiver: the President can temporarily waive sanctions for up to 180 days, with a sunset limit of five years from enactment.
  • 10Reporting obligations: The President must report to Congress on progress and compliance at specified intervals (120 days and 210 days) and provide final determinations about addressal and treaty compliance.
  • 11Definitions and scope: Adds precise definitions for “covered act,” “covered treaty,” and defines a broad “foreign governmental entity” for purposes of applying sanctions.
  • 12Conforming amendment: Aligns references to the relevant subsection in the 1991 act to ensure consistency with the new process.

Impact Areas

Primary group/area affected:- Foreign governments and their official entities most closely associated with the implicated actor; U.S. foreign policy and national security apparatus; U.S. export control and sanctions regimes.Secondary group/area affected:- U.S. industry and businesses engaged in exports and compliance with the Commerce Control List, Export Administration Regulations (EAR), and U.S. Munitions List; chemical and pharmaceutical sectors involved in fentanyl precursors.Additional impacts:- U.S. foreign aid and assistance programs could be altered or conditioned based on sanction status.- U.S. diplomatic relations with target countries could deteriorate or be leveraged to encourage compliance and restitution.- International organizations and allies may be involved or consulted through reporting and verification of treaty compliance, potentially influencing global norms around chemical/biological program control and fentanyl precursor handling.Sponsor and current status indicate introduction in the Senate (January 9, 2025) with likely parallel actions needed in the House to become law.The act centers on a proactive, escalating sanctions mechanism tied to acts involving chemical/biological programs, explicitly including fentanyl-related precursors, and ties sanctions to demonstrable actions such as restitution and treaty compliance.
Generated by gpt-5-nano on Nov 18, 2025